{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-037578","form_type":"8-K","ticker":"ARMP","cik":"0000921114","company_name":"Armata Pharmaceuticals, Inc.","filed_at":"2024-03-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.298279+00:00","generated_at":"2026-06-04T09:28:17.026756+00:00","sec_items":["5.08","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Armata sets June 12, 2024 annual meeting; proposal deadline April 1","bullets":["Annual meeting scheduled for June 12, 2024 at 8:30 a.m. PT via virtual webcast.","Record date for stockholders is April 19, 2024.","Deadline for Rule 14a-8 proposals and advance notice director nominations is April 1, 2024 at 5:00 p.m. ET.","Meeting date is more than 30 days later than the 2023 annual meeting, prompting new deadlines."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-037578","json":"https://secwatch.observer/filing/0001104659-24-037578.json","markdown":"https://secwatch.observer/filing/0001104659-24-037578.md","text":"https://secwatch.observer/filing/0001104659-24-037578.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/921114/000110465924037578/0001104659-24-037578-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/921114/000110465924037578/tm249318d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T09:28:17.026756+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}